ClinicalTrials.Veeva

Menu

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

H

Haukeland University Hospital

Status

Enrolling

Conditions

Depressive Disorder

Treatments

Other: electroconvulsive therapy

Study type

Observational

Funder types

Other

Identifiers

NCT05388461
2018/2541

Details and patient eligibility

About

The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.

Full description

Patients reffered to electroconvulsive ECT are (after written consent) enroled in a research registry. Based on (clinician and patient rated) measures of depressive symptoms and overall cognitive function, the short and long-term (6 months) efficacy of ECT will be described, and factors predicting response and relapse identified.

The duration of possible cognitive impairment and factors predicting cognitive outcome will be examined.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,
  • written consent to enrolment into the Regional Register for neurostimulation.

Exclusion criteria

  • ECT performed on other indications than major depression.
  • No consent to the register.

Trial contacts and locations

2

Loading...

Central trial contact

Ute Kessler, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems